Publications Database

Harfterkamp M. et al. (2012)

A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

5(7), pp. 733-741.

Read Abstract (New Window)

Harfterkamp M. et al. (2014)

Atomoxetine in autism spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change.

Journal of Child and Adolescent Psychopharmacology

November, 24(9), pp. 481-485.

Read Abstract (New Window)

Harfterkamp M. et al. (2013)

Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: An open-label extension study.

Journal of Child and Adolescent Psychopharmacology

23(3), pp. 194-199.

Read Abstract (New Window)

Meer L. A. v. d. et al. (2013)

A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.

Journal of Clinical Psychopharmacology

December, 33(6), pp. 824-827.

Read Abstract (New Window)